Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedTwo location entries in the Locations list were renamed from 'Santiago de Cali' to 'Cali' for postal codes 76001 and 760042 in Valle del Cauca, Colombia.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedLocation naming updated from Bourgogne to Bourgogne-Franche-Comté for Dijon, France (21000); the core location data remains the same.SummaryDifference0.0%

- Check38 days agoChange DetectedMajor updates include a government-operating-status notice and a version bump to v3.2.0. The page now informs users about potential service disruption due to funding and provides links for status updates.SummaryDifference1%

- Check52 days agoChange DetectedNo meaningful content changes detected; the only change is the removal of the 'Back to Top' link.SummaryDifference0.0%

- Check59 days agoChange DetectedMinor UI/navigation update: add a Back to Top link and update the version label to v3.0.2, removing the old revision tag. No substantive content changes.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has been updated to a new version, v3.0.0-post.1-g752effb-HEAD, indicating a revision in the content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.